| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 52, 1235-1241, Copyright © 1981 by Endocrine Society
ARTICLES |
H Shamoon, R Hendler and RS Sherwin
We infused epinephrine, glucagon, and cortisol in combination into health overnight-fasted subjects in doses designed to simulate changes in severe stress. When all three hormones were infused simultaneously, glucose levels rose above 200 mg/dl in spite of a 100-200% increase in plasma insulin. In contrast, infusion of each hormone individually produced either a mild (less than 120 mg/dl) or a transient elevation in the plasma glucose concentration. With the combined hormone infusion, the increment in plasma glucose was 3-fold greater than the sum of the responses to the individual hormones (P less than 0.001). The marked hyperglycemia in this setting is a result of ongoing glucose overproduction which is stimulated by epinephrine and glucagon and sustained by cortisol. Furthermore, epinephrine (and possibly cortisol) inhibited glucose disposal despite concomitant hyperinsulinemia. In contrast to their effects on glucose regulation, the simultaneous infusion of epinephrine, glucagon, and cortisol failed to cause hyperketonemia. We conclude that the combined infusion of epinephrine, glucagon, and cortisol produces a greater than additive hyperglycemic response in normal humans. These data suggest that the clinical occurrence of fasting hyperglycemia in a setting of hypersecretion of multiple antiinsulin hormones (stress hyperglycemia) may result, at least in part, from synergistic interactions among these hormones.
This article has been cited by other articles:
![]() |
D. S. Ward, W. A. Voter, and S. Karan The effects of hypo- and hyperglycaemia on the hypoxic ventilatory response in humans J. Physiol., July 15, 2007; 582(2): 859 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Lee, D. Benjamin, and D. N. Herndon Nutrition Support Strategies for Severely Burned Patients Nutr Clin Pract, June 1, 2005; 20(3): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weise, B. Drinkard, S. L. Mehlinger, S. M. Holzer, G. Eisenhofer, E. Charmandari, G. P. Chrousos, and D. P. Merke Stress Dose of Hydrocortisone Is Not Beneficial in Patients with Classic Congenital Adrenal Hyperplasia Undergoing Short-Term, High-Intensity Exercise J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3679 - 3684. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S Lewis, S. L Kane-Gill, M. B. Bobek, and J. F Dasta Intensive Insulin Therapy for Critically Ill Patients Ann. Pharmacother., July 1, 2004; 38(7): 1243 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. de Metz, J. A. Romijn, E. Endert, M. T. Ackermans, G. J. Weverling, O. R. Busch, L. Th. de Wit, D. J. Gouma, I. J. M. t. Berge, and H. P. Sauerwein Interferon-{gamma} increases monocyte HLA-DR expression without effects on glucose and fat metabolism in postoperative patients J Appl Physiol, February 1, 2004; 96(2): 597 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, E. P. Donahue, P. Flakoll, and A. D. Cherrington Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E695 - E707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Desautes, J. P. Bidanel, D. Milan, N. Iannuccelli, Y. Amigues, F. Bourgeois, J. C. Caritez, C. Renard, C. Chevalet, and P. Mormede Genetic linkage mapping of quantitative trait loci for behavioral and neuroendocrine stress response traits in pigs J Anim Sci, September 1, 2002; 80(9): 2276 - 2285. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kitabchi, G. E. Umpierrez, M. B. Murphy, E. J. Barrett, R. A. Kreisberg, J. I. Malone, and B. M. Wall Management of Hyperglycemic Crises in Patients With Diabetes Diabetes Care, January 1, 2001; 24(1): 131 - 153. [Full Text] |
||||
![]() |
R. J. Sigal, S. J. Fisher, J. B. Halter, M. Vranic, and E. B. Marliss Glucoregulation during and after Intense Exercise: Effects of {beta}-Adrenergic Blockade in Subjects with Type 1 Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3961 - 3971. [Abstract] [Full Text] |
||||
![]() |
E. Cersosimo, P. Garlick, and J. Ferretti Insulin regulation of renal glucose metabolism in humans Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E78 - E84. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Genter, N. Berman, M. Jacob, and E. Ipp Counterregulatory hormones oscillate during steady-state hypoglycemia Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E821 - E829. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Raikkonen, R. Lassila, L. Keltikangas-Jarvinen, and A. Hautanen Association of Chronic Stress With Plasminogen Activator Inhibitor–1 in Healthy Middle-aged Men Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 363 - 367. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |